Yosipovitch, G. ., Zeidler, C. ., Apfelbacher, C. J. ., Laquer, V. ., Kim, B. S. ., Casillas, M. ., Pierce, E. ., Chen, S. ., Qiao, M. ., Agell, H. ., & Del Rosso, J. . (2023). Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year. SKIN The Journal of Cutaneous Medicine, 7(6), s273. https://doi.org/10.25251/skin.7.supp.273